A drug discovery platform company focused on structural biology, medicinal chemistry and cell biology.
A drug discovery technology and services company. Completed $54 million IPO in 2000 and acquired by DeCODE genetics inc.
A joint venture between MediChem and the Malaysian government developing HIV drugs. Acquired by Malaysian government in 2006.
A drug development company focused on infection, cancer and respiratory diseases. Completed $35 million IPO in 2005.